 | Titan Pharmaceuticals, Inc. | |||
| NCM : TTNP || Location: United States | ||||
$6.970.0 (0.0%) |
0.0 M | 6.97 - 6.97 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| April 15, 2024 | 0.010 M |
| March 28, 2024 | 0.004 M |
| March 15, 2024 | 0.012 M |
| Feb. 29, 2024 | 0.012 M |
| Feb. 15, 2024 | 0.011 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 09/30/2021 | -0.36 | -0.19 | 46.78% |
| 06/30/2021 | -0.36 | -0.17 | 52.38% |
| 03/31/2021 | -0.87 | -0.28 | 67.70% |
| 12/31/2020 | -1.36 | -0.86 | 36.61% |
| 09/30/2020 | -1.05 | -1.50 | -42.90% |
TTNP Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 0.914M | Shares Float | 0.700M |
| Short Float | 0.010M | Market Cap | 6.37M |
| Institution ownership | 5.52% | Insider ownership | 45.469% |
| Earnings Date | Cash Per Share | ? | |
| Trailing EPS | -7.41 | Forward EPS | -0.91 |